HUMAN PROTEIN-C AND ACTIVATED PROTEIN-C - COMPONENTS OF THE HUMAN ANTICOAGULATION SYSTEM

被引:32
|
作者
CASTELLINO, FJ
机构
关键词
D O I
10.1016/1050-1738(94)00031-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Protein C, the zymogen form of the anticoagulant protein, activated protein C, is a member of the vitamin K-dependent class of proteins that function in generation and control of formation of blood clots. This plasma protein consists of a series of domain regions that are qualitatively similar to those present in human coagulation factors VII, IX, and X, and that appear to be related to specific properties of these proteins. With the recent advent of rigorous application of genetic engineering strategies to this system, and the continuing discoveries and characterization of genotypes and phenotypes of protein C in patients, great progress has been made in understanding structure-function relationships of protein C and activated protein C. This review is a summary and synthesis of recent pertinent studies with an emphasis on these topics.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 50 条
  • [1] SPECIFICITY OF ACTIVATED HUMAN PROTEIN-C
    STONE, SR
    HOFSTEENGE, J
    BIOCHEMICAL JOURNAL, 1985, 230 (02) : 497 - 502
  • [2] PROTEIN-C INHIBITOR - AN INHIBITOR FOR ACTIVATED PROTEIN-C
    MEIJERS, JCM
    VLOOSWIJK, RAA
    HESSING, M
    BOUMA, BN
    ARTERIOSCLEROSIS, 1988, 8 (05): : A685 - A685
  • [3] PURIFICATION AND INHIBITION OF HUMAN ACTIVATED PROTEIN-C
    TABY, O
    CHABBAT, J
    STEINBUCH, M
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 272 - 272
  • [4] EFFECT OF HUMAN PROTEIN-C AND ACTIVATED PROTEIN-C ON PLASMINOGEN-ACTIVATOR INHIBITOR IN ENDOTOXEMIA
    KOGA, S
    OKAJIMA, K
    INOUE, M
    NAKAGAKI, T
    OKABE, H
    FUNATSU, A
    TAKATSUKI, K
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 395 - 395
  • [5] EFFECT OF PROTEIN-C AND ACTIVATED PROTEIN-C ON COAGULATION AND FIBRINOLYSIS IN NORMAL HUMAN-SUBJECTS
    OKAJIMA, K
    KOGA, S
    KAJI, M
    IMAMURA, H
    OKABE, H
    TAKATSUKI, K
    AOKI, N
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 429 - 429
  • [6] EFFECT OF PROTEIN-C AND ACTIVATED PROTEIN-C ON COAGULATION AND FIBRINOLYSIS IN NORMAL HUMAN-SUBJECTS
    OKAJIMA, K
    KOGA, S
    KAJI, M
    INOUE, M
    NAKAGAKI, T
    FUNATSU, A
    OKABE, H
    TAKATSUKI, K
    AOKI, N
    THROMBOSIS AND HAEMOSTASIS, 1990, 63 (01) : 48 - 53
  • [7] PRECLINICAL PHARMACOLOGY OF ACTIVATED HUMAN PROTEIN-C
    BANG, NU
    EMERICK, SC
    MURAYAMA, H
    YAN, SB
    LONG, GL
    HARMS, CS
    MARKS, CA
    MATTLER, LE
    COMP, PC
    ESMON, NL
    ESMON, CT
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 181 - 181
  • [8] THE EFFECT OF LEUKOCYTE ELASTASE ON PROTEIN-C AND ACTIVATED PROTEIN-C
    PHILAPITSCH, A
    SCHWARZ, HP
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 724 - 724
  • [9] THE EFFECT OF PLASMIN ON PROTEIN-C AND ACTIVATED PROTEIN-C - A NEW REGULATORY MECHANISM OF THE PROTEIN-C PATHWAY
    VARADI, K
    PHILAPITSCH, A
    SANTA, T
    SCHWARZ, HP
    CIRCULATION, 1992, 86 (04) : 736 - 736
  • [10] MECHANISM OF INHIBITION OF ACTIVATED PROTEIN-C BY PROTEIN-C INHIBITOR
    SUZUKI, K
    NISHIOKA, J
    KUSUMOTO, H
    HASHIMOTO, S
    JOURNAL OF BIOCHEMISTRY, 1984, 95 (01): : 187 - 195